ciT1zen Science by the(sugar)science’s Podcast

T1D Cutting Edge Research - Episode 45 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Spurrell et al.

16 min · 29 de may de 2026
Portada del episodio T1D Cutting Edge Research - Episode 45 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Spurrell et al.

Descripción

In the forty-fifth episode of "Type 1 Diabetes: Cutting Edge Research" we discuss the paper The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy. Please note that podcasts were created with the help of notebookLM.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de ciT1zen Science by the(sugar)science’s Podcast!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

100 episodios